Health and Healthcare Systems

'No evidence' that recovered COVID-19 patients cannot be reinfected, according to WHO

Negative antibody tests are seen at a SOMOS Community Care COVID-19 antibody walk-in testing during the outbreak of the coronavirus disease (COVID-19) in Brooklyn, New York City, New York, U.S., April 24, 2020. REUTERS/Andrew Kelly - RC28BG9XFYPO

Scientists are still trying to understand if antibodies can prevent secondary COVID-19 infections. Image: REUTERS/Andrew Kelly

Stephanie Nebehay
Writer, Reuters
  • People who have recovered from COVID-19 still need to take precautions to prevent re-infection
  • Some countries have handed out “health passports” to people who have recovered from the illness
  • There are now 2.9 million cases of coronavirus confirmed globally

The World Health Organization (WHO) said on Saturday that there was currently “no evidence” that people who have recovered from COVID-19 and have antibodies are protected from a second coronavirus infection.

In a scientific brief, the United Nations agency warned governments against issuing “immunity passports” or “risk-free certificates” to people who have been infected as their accuracy could not be guaranteed.

The practice could actually increase the risks of continued spread as people who have recovered may ignore advice about taking standard precautions against the virus, it said.

“Some governments have suggested that the detection of antibodies to the SARS-CoV-2, the virus that causes COVID-19, could serve as the basis for an ‘immunity passport’ or ‘risk-free certificate’ that would enable individuals to travel or to return to work assuming that they are protected against re-infection,” the WHO said.

“There is currently no evidence that people who have recovered from COVID-19 and have antibodies are protected from a second infection,” it said.

Chile said last week it would begin handing out “health passports” to people deemed to have recovered from the illness. Once screened to determine if they have developed antibodies to make them immune to the virus, they could immediately rejoin the workforce.

The WHO said it continued to review the evidence on antibody responses to the virus, which emerged in the central Chinese city of Wuhan late last year. Some 2.8 million people have been reported to be infected by the novel coronavirus globally and 196,298 have died, according to a Reuters tally.

Coronavirus confirmed cases
There are more than 2.9 million confirmed cases of COVID-19 worldwide. Image: Our World in Data

Most studies have shown that people who have recovered from infection have antibodies to the virus, the WHO said. However, some of them have very low levels of neutralizing antibodies in their blood, “suggesting that cellular immunity may also be critical for recovery”, it added.

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Stay up to date:

COVID-19

Share:
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

How COVID-19 unleashed a wave of medical oxygen innovation

Evan Spark-DePass

November 14, 2024

Billions of dollars have been invested in healthcare AI. But are we spending in the right places?

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2024 World Economic Forum